BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8002632)

  • 1. [Glutathione S transferases-pi].
    Takahashi Y; Niitsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
    Ban N; Takahashi Y; Takayama T; Kura T; Katahira T; Sakamaki S; Niitsu Y
    Cancer Res; 1996 Aug; 56(15):3577-82. PubMed ID: 8758929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-cancer drug resistance and glutathione S-transferases].
    Sato K; Tsuchida S; Tamai K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):592-8. PubMed ID: 2650631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA; Townsend AJ; Cowan KH
    Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    Townsend AJ; Tu CP; Cowan KH
    Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
    Wang X; Kong L; Zhao J; Yang P
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of glutathione S-transferase pi in tumor drug resistance].
    Cao W; Zuo J; Fang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):402-6. PubMed ID: 12567441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Kikkawa F; Tamakoshi K; Obata NH; Mizuno K; Suganuma N; Tomoda Y; Kuzuya K; Ishikawa T; Hidaka H
    Anticancer Res; 1997; 17(3C):1985-92. PubMed ID: 9216655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue.
    Terrier P; Townsend AJ; Coindre JM; Triche TJ; Cowan KH
    Am J Pathol; 1990 Oct; 137(4):845-53. PubMed ID: 1977319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of cytosolic glutathione S-transferases in drug-resistant L5178Y murine lymphoblasts: chemical selectivity and molecular mechanisms.
    Stelmack GL; Goldenberg GJ
    Cancer Res; 1993 Aug; 53(15):3530-5. PubMed ID: 8101761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-associated enzymes in anticancer drug resistance.
    Tew KD
    Cancer Res; 1994 Aug; 54(16):4313-20. PubMed ID: 8044778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
    Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
    Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pi form of glutathione S-transferase (GST-pi) in cancer: a minireview.
    Gajewska J; Szczypka M
    Mater Med Pol; 1992; 24(1):45-9. PubMed ID: 1308270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of the placental glutathione S-transferase form (GST-pi) in tumor tissues and the levels in sera of patients with cancer.
    Tsuchida S; Sekine Y; Shineha R; Nishihira T; Sato K
    Cancer Res; 1989 Sep; 49(18):5225-9. PubMed ID: 2504486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of glutathione and associated enzymes in drug response.
    Shen H; Kauvar L; Tew KD
    Oncol Res; 1997; 9(6-7):295-302. PubMed ID: 9406235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.